Detalhe da pesquisa
1.
Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study.
Ann Surg
; 277(2): e313-e319, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334634
2.
Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.
Acta Oncol
; 59(7): 753-759, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400242
3.
ASO Author Reflections: Preoperative Selection of cT4b Esophageal Cancer Patients Who Benefit From a Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE).
Ann Surg Oncol
; 28(5): 2739-2740, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263828
4.
A robust semi-automatic delineation workflow using denoised diffusion weighted magnetic resonance imaging for response assessment of patients with esophageal cancer treated with neoadjuvant chemoradiotherapy.
Phys Imaging Radiat Oncol
; 28: 100489, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822533
5.
The Presence of Metastatic Thoracic Duct Lymph Nodes in Western Esophageal Cancer Patients: A Multinational Observational Study.
Ann Thorac Surg
; 113(2): 429-435, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676903
6.
An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
Radiother Oncol
; 162: 76-84, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237345
7.
The anatomy of the thoracic duct at the level of the diaphragm: A cadaver study.
Ann Anat
; 217: 47-53, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510243
8.
Two-Field Lymphadenectomy During Esophagectomy: The Presence of Thoracic Duct Lymph Nodes.
Ann Thorac Surg
; 106(2): 435-439, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29580778
9.
Restaging after chemoradiotherapy for locally advanced esophageal cancer.
Ann Transl Med
; 7(Suppl 8): S288, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32016007